Information Session on the PMPRB Guidelines Modernization Discussion Paper
On August 23rd, 2016, PDCI Market Access Inc., Canada’s leading pricing and reimbursement consultancy, held a free “Information Session on the PMPRB Guidelines Modernization Discussion Paper”. This came shortly after the PMPRB recently releasing its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”.
This webinar session touched on the potential repercussions of these changes on Canadian drug prices and implications for pharmaceutical companies. Neil Palmer, the President & Principal Consultant at PDCI led this engaging session that provided background and context, outlined the timelines for these changes and discussed the potential impact and implications.
Due to its great success and initial demand for a repeat session for those who missed the first webinar, PDCI is considering holding a 2nd session tentatively scheduled for September 8th, 2016 10 a.m. – 12 p.m. (noon). PDCI will confirm date and time if there is sufficient demand.
If interested in attending the 2nd webinar, please contact Carla Freige at Carla.Freige@pdci.ca (+1613-742-8225 ext. 43). If there is sufficient interest, GoToMeeting registration details will be published in TargetPharma.
Please note that this information webinar session is for industry representatives only (no consultants!). All registrants must use their pharma company e-mail address to register (no hotmail, Gmail, etc. e-mail addresses).